Wang Xiao-Hua, Yao Dong-Xu, Luan Xiu-Shu, Wang Yu, Liu Hai-Xia, Liu Bei, Liu Yang, Zhao Lei, Ji Xun-Ming, Wang Tian-Long
Department of Anesthesiology, Xuanwu Hospital, Capital Medical University; Institute of Geriatrics; National Clinical Research Center for Geriatric Disorders, Beijing, China.
Department of Neurosurgery; Cerebrovascular Research Center, Xuanwu Hospital, Capital Medical University, Beijing, China.
Neural Regen Res. 2019 Nov;14(11):2003-2010. doi: 10.4103/1673-5374.253174.
Using deep hypothermic circulatory arrest, thoracic aorta diseases and complex heart diseases can be subjected to corrective procedures. However, mechanisms underlying brain protection during deep hypothermic circulatory arrest are unclear. After piglet models underwent 60 minutes of deep hypothermic circulatory arrest at 14°C, expression of microRNAs (miRNAs) was analyzed in the hippocampus by microarray. Subsequently, TargetScan 6.2, RNA22 v2.0, miRWalk 2.0, and miRanda were used to predict potential targets, and gene ontology enrichment analysis was carried out to identify functional pathways involved. Quantitative reverse transcription-polymerase chain reaction was conducted to verify miRNA changes. Deep hypothermic circulatory arrest altered the expression of 35 miRNAs. Twenty-two miRNAs were significantly downregulated and thirteen miRNAs were significantly upregulated in the hippocampus after deep hypothermic circulatory arrest. Six out of eight targets among the differentially expressed miRNAs were enriched for neuronal projection (cyclin dependent kinase, CDK16 and SLC1A2), central nervous system development (FOXO3, TYRO3, and SLC1A2), ion transmembrane transporter activity (ATP2B2 and SLC1A2), and interleukin-6 receptor binding (IL6R) - these are the key functional pathways involved in cerebral protection during deep hypothermic circulatory arrest. Quantitative reverse transcription-polymerase chain reaction confirmed the results of microarray analysis. Our experimental results illustrate a new role for transcriptional regulation in deep hypothermic circulatory arrest, and provide significant insight for the development of miRNAs to treat brain injuries. All procedures were approved by the Animal Care Committee of Xuanwu Hospital, Capital Medical University, China on March 1, 2017 (approval No. XW-INI-AD2017-0112).
使用深低温停循环技术,可以对胸主动脉疾病和复杂心脏病进行矫正手术。然而,深低温停循环期间脑保护的潜在机制尚不清楚。在仔猪模型于14°C下进行60分钟深低温停循环后,通过微阵列分析海马体中微小RNA(miRNA)的表达。随后,使用TargetScan 6.2、RNA22 v2.0、miRWalk 2.0和miRanda预测潜在靶点,并进行基因本体富集分析以确定相关的功能途径。进行定量逆转录-聚合酶链反应以验证miRNA的变化。深低温停循环改变了35种miRNA的表达。深低温停循环后,海马体中有22种miRNA显著下调,13种miRNA显著上调。差异表达的miRNA中的8个靶点中有6个在神经元投射(细胞周期蛋白依赖性激酶,CDK16和SLC1A2)、中枢神经系统发育(FOXO3、TYRO3和SLC1A2)、离子跨膜转运体活性(ATP2B2和SLC1A2)和白细胞介素-6受体结合(IL6R)方面富集,这些是深低温停循环期间脑保护所涉及的关键功能途径。定量逆转录-聚合酶链反应证实了微阵列分析的结果。我们的实验结果阐明了转录调控在深低温停循环中的新作用,并为开发用于治疗脑损伤的miRNA提供了重要见解。所有程序均于2017年3月1日获得中国首都医科大学宣武医院动物护理委员会的批准(批准号:XW-INI-AD2017-0112)。